HAEMONETICS CORP/MASS (HAE)
US4050241003 - Common Stock
While growth is established for NYSE:HAE, the stock's valuation remains reasonable.
For those who appreciate growth without the sticker shock, HAEMONETICS CORP/MASS (NYSE:HAE) is worth considering.
HAE February 2025 Options Begin Trading
Haemonetics (HAE) Shares Cross Below 200 DMA
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Haemonetics (HAE) Shares Cross Above 200 DMA
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024,...
Haemonetics Larger Than S&P 500 Component Deckers Outdoor
Notable Tuesday Option Activity: APLS, HAE, LULU
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2025 financial results at 6:00 am...
Notable Thursday Option Activity: HAE, BA, PGY
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
Haemonetics is Now Oversold (HAE)
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient...
Relative Strength Alert For Haemonetics
Haemonetics Breaks Below 200-Day Moving Average - Notable for HAE
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2025, which ended June 29, 2024, are...
Sotera Health Appoints Christopher Simon to the Board of Directors
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better...
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am...
October 2025 Options Now Available For Haemonetics Corp. (HAE)
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient...